Home / ATTBF : OTC

AI Analysis Fundamentals Video Analysis Similar

AI Analysis

How does ATTBF make money? Does ATTBF have pricing power? What's the Earnings Whisper? Will ATTBF profit more as the business scales? What is ATTBF's management track record? Is ATTBF's current price justified?

Abattis Bioceuticals Corp.

$0 +$0.00 (+0.00%)

OTC · 11 Sep 2026 20:00 UTC

Previous Close

Day Range

$0$0

Year Range

$0$0

Market Cap

14.33K

AVG Volume

22.32K

Trailing/Forward PE

-0.01/-

PEG ratio

-0

Dividend Yield

Next Earnings Date

Primary Exchange

Other OTC

Revenue (CAD)

ATTBF Revenue (CAD) by year
Period	Revenue (CAD)
2019	356.88K
2018	8.37K
2017	0
2016	-1
2015	75.61K
2014	7.72K
2013	16.82K
2012	0
2011	0
2010	0

Net Income (CAD)

ATTBF Net Income (CAD) by year
Period	Net Income (CAD)
2019	-3.04M
2018	-78.01M
2017	-7.63M
2016	-2.34M
2015	-4.47M
2014	-7.57M
2013	-1.14M
2012	-992.39K
2011	-1.42M
2010	-759.11K

Operating Income (CAD)

ATTBF Operating Income (CAD) by year
Period	Operating Income (CAD)
2019	-3.91M
2018	-17.38M
2017	-6.36M
2016	-2.4M
2015	-3.09M
2014	-7.35M
2013	-1.06M
2012	-1.01M
2011	-1.42M
2010	-760K

EBITDA (CAD)

ATTBF EBITDA (CAD) by year
Period	EBITDA (CAD)
2019	-2.9M
2018	-17.34M
2017	-6.71M
2016	-2.13M
2015	-3.18M
2014	-7.23M
2013	-983.09K
2012	-936.45K
2011	-1.39M
2010	-709.27K

Cash Flows (CAD)

ATTBF Cash Flows (CAD) by year
Period	Cash Flows (CAD)
2019	4.35M
2018	-8.51M
2017	-1.65M
2016	-777.31K
2015	-1.97M
2014	-2.41M
2013	-230.15K
2012	-333.5K
2011	-496.19K
2010	-324.51K

EPS (CAD)

ATTBF EPS (CAD) by year
Period	EPS (CAD)
2019	-0.01
2018	-0.22
2017	-0.05
2016	-0.03
2015	-0.06
2014	-0.17
2013	-0.05
2012	-0.09
2011	-0.14
2010	-0.15

Expenses (CAD)

ATTBF Expenses (CAD) by year
Period	Expenses (CAD)
2019	9.21M
2018	16.03M
2017	6.67M
2016	2.32M
2015	3.11M
2014	7.56M
2013	988.48K
2012	1.05M
2011	1.58M
2010	557.22K

Cash & Debt (CAD)

ATTBF Cash & Debt (CAD) by year
Period	Cash & Debt (CAD)
2019	2.4M
2018	9.1M
2017	525.57K
2016	38.48K
2015	257.52K
2014	1.36M
2013	5.33K
2012	5.5K
2011	5.87K
2010	348.9K

Debt ratios

ATTBF Debt ratios by year
Period	Debt ratios
2019	0.03
2018	0.31
2017	0.03
2016	0
2015	0.02
2014	0.13
2013	-0.15
2012	-0.05

Margins

ATTBF Margins by year
Period	Margins
2019	67.62%
2018	77.37%
2016	100%
2015	78.35%
2014	100%
2013	29.81%

Return on Capital

ATTBF Return on Capital by year
Period	Return on Capital
2019	-28.52%
2018	-703.05%
2017	-989.53%
2016	-1115.18%
2015	-938.27%
2014	-163.03%
2013	-204.74%
2012	-159.17%
2011	-240.1%
2010	-199.76%

Shares Outstanding

ATTBF Shares Outstanding by year
Period	Shares Outstanding
2019	477.88M
2018	420.96M
2017	187.5M
2016	120.05M
2015	73.33M
2014	64.44M
2013	28.61M
2012	11.73M
2011	10.7M
2010	5.13M

Book Value Per Share (CAD)

ATTBF Book Value Per Share (CAD) by year
Period	Book Value Per Share (CAD)
2019	0.02
2018	0.03
2017	0
2016	0
2015	0.01
2014	0.07
2013	0.02
2012	0.05
2011	0.06
2010	0.07

Total Assets (CAD)

ATTBF Total Assets (CAD) by year
Period	Total Assets (CAD)
2019	19.26M
2018	11.4M
2017	1.21M
2016	1.27M
2015	1.61M
2014	5.9M
2013	1.63M
2012	1.33M
2011	718.06K
2010	812.61K

No video analysis for this stock yet. Request one from our team.

AI Analysis

Abattis Bioceuticals Corp.

Video analysis: ATTBF

Similar companies